腱鞘积液作为胫骨后肌腱形态正常患者早期胫骨后肌腱功能障碍的指征
研究纳入326例无肌腱实质内病变的内踝疼痛患者,比较临床诊断1期胫骨后肌腱功能障碍(48例)、其他原因内踝疼痛(278例)与无症状对照(56例)的MRI腱鞘积液量。1期功能障碍组积液体积、面积和宽度均大于其他两组(均P<0.001),最大积液宽度9 mm阈值诊断敏感度84%、特异度85%。
要点
- 临床诊断1期胫骨后肌腱功能障碍者MRI腱鞘积液体积、最大横截面积和宽度均大于其他原因内踝疼痛者及无症状对照(均P<0.001)。
- 最大积液宽度≥9 mm与胫骨后肌腱功能障碍相关,敏感度84%、特异度85%。
- 三名观察者在不知金标准情况下测量,可靠性检验均P<0.03。
核心结论
- 1期胫骨后肌腱功能障碍患者腱鞘积液量大于其他原因内踝疼痛者和无症状对照,最大积液宽度≥9 mm可区分该病;在无MRI可检测肌腱实质内病变时,腱鞘积液扩张与临床诊断的关联可能有助于鉴别内踝疼痛来源并可能允许早期干预以预防进展。证据等级为预后性(III级)。
研究设计与样本
- 共研究326例内踝疼痛且无胫骨后肌腱实质内病变的个体:第1组为临床诊断1期胫骨后肌腱功能障碍的48例患者,第2组为其他原因内踝疼痛的278例患者,第3组为无内踝疼痛的56例对照;采用基于MRI的几何测量包括胫骨后肌腱积液体积、最大横截面积液面积和积液宽度,比较组间积液测量值并检验测量可靠性。
诊断标准与关键数值
- 最大积液宽度9 mm阈值与胫骨后肌腱功能障碍相关,敏感度84%、特异度85%;第1组胫骨后肌腱积液体积、面积和宽度均大于第2组(其他原因内踝疼痛)和第3组(无症状对照),所有P值<0.001;三名观察者间测量可靠性检验所有P值<0.03。
临床应用与阅片要点
- 作者认为,在无MRI可检测肌腱实质内病变时,腱鞘积液扩张与临床诊断1期胫骨后肌腱疾病的关联可能有助于区分内踝疼痛的其他来源,并可能允许早期干预以预防胫骨后肌腱功能障碍进展。
局限性
- 证据等级为预后性(III级)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Our primary aim was to quantify the posterior tibial tendon (PTT) sheath fluid volume in individuals with the clinical diagnosis of stage 1 posterior tibial tendon dysfunction (PTTD) and no MRI-detectable intra-substance tendon pathology and compare them with patients with other causes of medial ankle pain, also without MRI-detectable intra-substance PTT pathology and with normal controls. We also wanted to determine if there is a fluid measurement that correlates with the clinical diagnosis of PTTD.
MATERIALS AND METHODS: A total of 326 individuals with medial ankle pain and no intra-substance PTT pathology were studied. Group 1 included 48 patients with a clinical diagnosis of stage 1 PTT dysfunction, group 2 comprised 278 patients with other causes of medial ankle pain, and a third control group consisted of 56 patients without any medial ankle pain. MRI-based geometric measurements included PTT fluid volume, maximum cross-sectional fluid area, and fluid width. Fluid measurements were compared between groups and measurement reliability was tested.
RESULTS: Group 1 showed greater PTT fluid volume, area, and width compared with groups 2 (other causes of medial ankle pain) and 3 (asymptomatic controls) (all p values < 0.001). A 9-mm threshold maximum fluid width was associated with PTTD (sensitivity 84%, specificity 85%). Measurements were reliable (all p values < 0.03) among three observers blinded to the gold standard.
CONCLUSION: Patients with stage 1 PTT dysfunction displayed greater volumes of tendon-sheath fluid than those with other causes of medial ankle pain and compared with asymptomatic controls. A threshold maximum fluid width greater than or equal to 9 mm distinguishes those with PTTD. An association between tendon sheath fluid distension and the clinical diagnosis of stage 1 posterior tibial tendon disease in the setting of no MRI-detectable intra-substance tendon pathology may allow for differentiation of medial ankle pain from other sources and may allow for early intervention aimed at preventing progressive PTTD. The level of evidence was prognostic (level III).
引用
- Gonzalez FM, Harmouche E, Robertson DD, et al. Tenosynovial fluid as an indication of early posterior tibial tendon dysfunction in patients with normal tendon appearance. Skeletal Radiol. 2019. PMID: 30778639. doi:10.1007/s00256-018-3142-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。